
Corbotics aims to increase the capacity for standard Transthoracic Echocardiogram (TTE) examinations by automating the acquisition of echo clips for outpatient care. They leverage patented AI techniques and robotics to consistently generate clinically usable echocardiograms, which are used by cardiologists to diagnose heart disease. The company's ambition is to improve heart diagnostics through the use of robotics and artificial intelligence, believing that better technology can lead to the diagnosis of heart problems that currently go undetected.

Corbotics aims to increase the capacity for standard Transthoracic Echocardiogram (TTE) examinations by automating the acquisition of echo clips for outpatient care. They leverage patented AI techniques and robotics to consistently generate clinically usable echocardiograms, which are used by cardiologists to diagnose heart disease. The company's ambition is to improve heart diagnostics through the use of robotics and artificial intelligence, believing that better technology can lead to the diagnosis of heart problems that currently go undetected.